Live from the NIH registry
Studies recruiting near Gastonia right now
Top 25 of 651 recruiting studies, sorted by proximity — each links to its official registry page
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Novant Health Presbyterian Medical Center — Charlotte, North Carolina (19.4 mi)
· Sponsor: SWOG Cancer Research Network
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Carolinas Medical Center/Levine Cancer Institute — Charlotte, North Carolina (19.4 mi)
· Sponsor: National Cancer Institute (NCI)
Study to Evaluate the REMEDY SPECTRUM GV IM Spacer Nail in the Treatment of Ankle-Related Infections
Periprosthetic Joint Infection
Phase 2
Interventional 60 participants sought
OrthoCarolina Research Institute — Charlotte, North Carolina (19.4 mi)
· Sponsor: OsteoRemedies, LLC
A Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Following Adjuvant Therapy (MK-6482-033)
Renal Cell Carcinoma
Phase 3
Interventional 904 participants sought
Carolina Oncology Specialists, PA ( Site 9002) — Charlotte, North Carolina (19.4 mi)
· Sponsor: Merck Sharp & Dohme LLC
E-Mindfulness Approaches for Living After Breast Cancer
Breast Cancer, Depression
Phase 3
Interventional 402 participants sought
Levine Cancer Institute-Gaston — Gastonia, North Carolina (0.9 mi)
· Sponsor: NRG Oncology
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Endometrial Cancer
Phase 3
Interventional 600 participants sought
Research Site — Charlotte, North Carolina (19.4 mi)
· Sponsor: AstraZeneca
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Carcinoma, Transitional Cell, Urinary Bladder Neoplasms
Phase 3
Interventional 450 participants sought
Levine Cancer Institute — Charlotte, North Carolina (19.4 mi)
· Sponsor: Eli Lilly and Company
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Bladder Carcinoma, Ureter Carcinoma
N/A
Observational 2,020 participants sought
Carolina Blood and Cancer Care Associates — Rock Hill, South Carolina (24.2 mi)
· Sponsor: Guardant Health, Inc.
Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
Neuroblastoma
Phase 2
Interventional 93 participants sought
Levine Children's Hospital — Charlotte, North Carolina (19.4 mi)
· Sponsor: Giselle Sholler
A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)
Heart Failure
Phase 3
Interventional 1,500 participants sought
CON-10318, Charlotte, NC — Charlotte, North Carolina (19.4 mi)
· Sponsor: Colorado Prevention Center
A Study of Dotinurad Versus Allopurinol in Participants With Gout
Gout
Phase 3
Interventional 500 participants sought
DelRicht Research — Charlotte, North Carolina (19.4 mi)
· Sponsor: Crystalys Therapeutics
ALLIANCE AVIV: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve in Failing Aortic Bioprosthetic Valves
Aortic Valve Insufficiency, Aortic Valve Stenosis
N/A
Interventional 200 participants sought
Carolinas Health System — Charlotte, North Carolina (19.4 mi)
· Sponsor: Edwards Lifesciences
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
Percutaneous Coronary Intervention, Peripheral Endovascular Intervention
Phase 4
Interventional 6,000 participants sought
Novant Health Clinical Research/Heart & Vascular Institute — Charlotte, North Carolina (19.4 mi)
· Sponsor: Duke University
A Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension
Uncontrolled Hypertension
Phase 2
Interventional 280 participants sought
Retension Clinical Site — Charlotte, North Carolina (19.4 mi)
· Sponsor: Retension Pharmaceuticals. Inc.
A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma
Multiple Myeloma, Myeloma
Phase 1
Interventional 165 participants sought
Atrium Health, Levine Cancer Institute — Charlotte, North Carolina (19.4 mi)
· Sponsor: K36 Therapeutics, Inc.
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Phase 3
Interventional 1,200 participants sought
Carolina Oncology Specialists, PA ( Site 0054) — Charlotte, North Carolina (19.4 mi)
· Sponsor: Merck Sharp & Dohme LLC
Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma
Asthma
Phase 3
Interventional 440 participants sought
Research Site — Charlotte, North Carolina (19.4 mi)
· Sponsor: AstraZeneca
A Study to Evaluate the Efficacy and Safety of E2086 in Adults With Narcolepsy
Narcolepsy
Phase 2
Interventional 64 participants sought
Research Carolina Elite — Denver, North Carolina (21.4 mi)
· Sponsor: Eisai Inc.
Assoc. of Genomic Polymorphisms With Cancer Cachexia in Subjects With Panc Adenocarcinoma
Pancreas Adenocarcinoma, Cachexia
N/A
Observational 100 participants sought
Levine Cancer Institute — Charlotte, North Carolina (19.4 mi)
· Sponsor: Wake Forest University Health Sciences
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Triple-Negative Breast Cancer
Phase 3
Interventional 1,530 participants sought
Levine Cancer Institute ( Site 0083) — Charlotte, North Carolina (19.4 mi)
· Sponsor: Merck Sharp & Dohme LLC
Phase 3 Pivotal Trial Comparing CARTISTEM® and Surgical Comparator for Knee Cartilage Lesions and Osteoarthritis
Knee Cartilage Defects
Phase 3
Interventional 300 participants sought
Atrium Health Mercy — Charlotte, North Carolina (19.4 mi)
· Sponsor: Medipost, Inc.
Evaluating the Safety and Efficacy of Polyethylene Glycol (PEG) Mediated Fusion (PEG Fusion)
Peripheral Nerve Injuries
Phase 2
Interventional 40 participants sought
OrthoCarolina — Charlotte, North Carolina (19.4 mi)
· Sponsor: Major Extremity Trauma Research Consortium
A Study to Learn About the Study Medicine Called Rimegepant in Adolescents With Frequent Migraine
Migraine
Phase 3
Interventional 200 participants sought
OnSite Clinical Solutions — Charlotte, North Carolina (19.4 mi)
· Sponsor: Pfizer
A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Idiopathic Hypersomnia (IH)
Idiopathic Hypersomnia
Phase 3
Interventional 248 participants sought
Clinical Research of Gastonia — Gastonia, North Carolina (0.9 mi)
· Sponsor: Harmony Biosciences Management, Inc.
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm
Phase 2
Interventional 2,000 participants sought
Carolinas Medical Center/Levine Cancer Institute — Charlotte, North Carolina (19.4 mi)
· Sponsor: National Cancer Institute (NCI)